{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:50:04Z","timestamp":1780527004133,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jpsychires.2021.10.026","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T23:26:29Z","timestamp":1635290789000},"page":"412-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Urological adverse drug reactions of psychotropic medication in psychiatric inpatients \u2013 A drug surveillance report from German-speaking countries"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8849-9907","authenticated-orcid":false,"given":"Dietmar","family":"Winkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Grohmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela-Elena","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sermin","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bleich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Konstantinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Pjrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpsychires.2021.10.026_bib1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.jpsychires.2021.10.026_bib2","first-page":"1051","article-title":"Urinary retention with sertraline, haloperidol, and clonazepam combination","volume":"43","author":"Benazzi","year":"1998","journal-title":"Can. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1464-410X.2003.04369.x","article-title":"The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study","volume":"92","author":"Boyle","year":"2003","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.10.026_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11302-013-9395-y","article-title":"Purinergic signalling in the urinary tract in health and disease","volume":"10","author":"Burnstock","year":"2014","journal-title":"Purinergic Signal."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.10.026_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jemermed.2003.12.005","article-title":"Urinary retention due to clonazepam in a child with dyskinetic cerebral palsy","volume":"26","author":"Caksen","year":"2004","journal-title":"J. Emerg. Med."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.10.026_bib6","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/cap.2011.0071","article-title":"Risperidone and double incontinence in a child with autism","volume":"21","author":"Cop","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.10.026_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0733-8627(05)70205-4","article-title":"Acute urinary retention and urinary incontinence","volume":"19","author":"Curtis","year":"2001","journal-title":"Emerg. Med. Clin."},{"issue":"5","key":"10.1016\/j.jpsychires.2021.10.026_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2042098618756261","article-title":"Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine","volume":"9","author":"De Berardis","year":"2018","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.10.026_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/j.2040-4603.2015.tb00596.x","article-title":"Neural control of the lower urinary tract","volume":"5","author":"de Groat","year":"2015","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.jpsychires.2021.10.026_bib10","author":"Devleesschauwer"},{"issue":"9","key":"10.1016\/j.jpsychires.2021.10.026_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/15622975.2018.1500030","article-title":"Seizure rates under treatment with antipsychotic drugs: data from the AMSP project","volume":"20","author":"Druschky","year":"2019","journal-title":"World J. Biol. Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2021.10.026_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40263-017-0448-6","article-title":"Clozapine-induced gastrointestinal hypomotility: a 22-year Bi-national pharmacovigilance study of serious or fatal 'slow gut' reactions, and comparison with international drug safety advice","volume":"31","author":"Every-Palmer","year":"2017","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv126","article-title":"Drug-induced liver injury during antidepressant treatment: results of AMSP, a drug surveillance program","volume":"19","author":"Friedrich","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.10.026_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ijnp\/pyz046","article-title":"Cardiovascular adverse reactions during antipsychotic treatment: results of AMSP, A drug surveillance program between 1993 and 2013","volume":"23","author":"Friedrich","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.jpsychires.2021.10.026_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4088\/JCP.v57n1102","article-title":"Clozapine-induced urinary incontinence: incidence and treatment with ephedrine","volume":"57","author":"Fuller","year":"1996","journal-title":"J. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/030006059302100405","article-title":"Acute fluvoxamine poisoning","volume":"21","author":"Garnier","year":"1993","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2021.10.026_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00406-013-0419-y","article-title":"Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study","volume":"264","author":"Grohmann","year":"2014","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2021.10.026_bib18","first-page":"S4","article-title":"The AMSP drug safety program: methods and global results","volume":"37","author":"Grohmann","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"5643","key":"10.1016\/j.jpsychires.2021.10.026_bib19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.1.5643.531","article-title":"Intensive hospital monitoring of adverse reactions to drugs","volume":"1","author":"Hurwitz","year":"1969","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00213-001-0971-4","article-title":"Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study","volume":"159","author":"Kasper","year":"2002","journal-title":"Psychopharmacology (Berlin)"},{"issue":"5","key":"10.1016\/j.jpsychires.2021.10.026_bib21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/JCP.0000000000000197","article-title":"Risperidone-associated urinary incontinence in patients with autistic disorder with mental retardation","volume":"34","author":"Kumazaki","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.10.026_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1067\/mcp.2002.129318","article-title":"Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community","volume":"72","author":"Landi","year":"2002","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.10.026_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3346\/jkms.2010.25.2.333","article-title":"Use of aripiprazole in clozapine induced enuresis: report of two cases","volume":"25","author":"Lee","year":"2010","journal-title":"J. Kor. Med. Sci."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.10.026_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11255-013-0410-6","article-title":"The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis","volume":"45","author":"Li","year":"2013","journal-title":"Int. Urol. Nephrol."},{"issue":"11","key":"10.1016\/j.jpsychires.2021.10.026_bib25","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/sj.npp.1300768","article-title":"N-desmethylclozapine, a major metabolite of clozapine, increases cortical acetylcholine and dopamine release in vivo via stimulation of M1 muscarinic receptors","volume":"30","author":"Li","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.10.026_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1600-0447.1999.tb10837.x","article-title":"A retrospective study of clozapine and urinary incontinence in Chinese in-patients","volume":"100","author":"Lin","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pds.705","article-title":"Selective serotonin reuptake inhibitor-induced urinary incontinence","volume":"11","author":"Movig","year":"2002","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jpsychires.2021.10.026_bib28","author":"Nakazawa"},{"issue":"1","key":"10.1016\/j.jpsychires.2021.10.026_bib29","first-page":"77","article-title":"Paroxetine-the antidepressant from hell? Probably not, but caution required","volume":"46","author":"Nevels","year":"2016","journal-title":"Psychopharmacol. Bull."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00213-021-05767-1","article-title":"Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment","volume":"238","author":"Ng","year":"2021","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2021.10.026_bib31","series-title":"Evaluating the Role of Ketamine\/Esketamine in the Management of Major Depressive Disorder with Suicide Risk","author":"Nikayin","year":"2021"},{"issue":"3","key":"10.1016\/j.jpsychires.2021.10.026_bib32","doi-asserted-by":"crossref","DOI":"10.1176\/jnp.2010.22.3.352.e21","article-title":"Mirtazapine-associated urinary retention","volume":"22","author":"Oulis","year":"2010","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.10.026_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.jcp.0000246219.35809.fd","article-title":"Urinary obstruction with citalopram and aripiprazole combination in an elderly patient","volume":"26","author":"Padala","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2021.10.026_bib34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2125.2006.02748.x","article-title":"Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea","volume":"63","author":"Praharaj","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpsychires.2021.10.026_bib35","series-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2020"},{"issue":"2\u20133","key":"10.1016\/j.jpsychires.2021.10.026_bib36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0278-5846(88)90039-5","article-title":"Anticholinergic side effects of tricyclic antidepressants and their management","volume":"12","author":"Remick","year":"1988","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/YIC.0000000000000023","article-title":"A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?","volume":"29","author":"Sanchez","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.10.026_bib38","first-page":"230","article-title":"Urinary incontinence associated with clonazepam therapy","volume":"64","author":"Sandyk","year":"1983","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.jpsychires.2021.10.026_bib39","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2105\/AJPH.55.8.1170","article-title":"Epidemiological studies of adverse drug reactions","volume":"55","author":"Seidl","year":"1965","journal-title":"Am. J. Public Health Nation's Health"},{"key":"10.1016\/j.jpsychires.2021.10.026_bib40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jad.2020.12.073","article-title":"Time trends in pharmacological treatment of major depressive disorder: results from the AMSP Pharmacovigilance Program from 2001-2017","volume":"281","author":"Seifert","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.10.026_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060863","article-title":"Prevalence and predictors of clozapine-associated constipation: a systematic review and meta-analysis","volume":"17","author":"Shirazi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.jpsychires.2021.10.026_bib42","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/PL00014139","article-title":"Medical treatment and medical side effects in urinary incontinence in the elderly","volume":"16","author":"Thuroff","year":"1998","journal-title":"World J. Urol."},{"issue":"4","key":"10.1016\/j.jpsychires.2021.10.026_bib43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4088\/JCP.v59n0407","article-title":"Relation of serum anticholinergicity to cognitive status in schizophrenia patients taking clozapine or risperidone","volume":"59","author":"Tracy","year":"1998","journal-title":"J. Clin. Psychiatr."},{"issue":"6","key":"10.1016\/j.jpsychires.2021.10.026_bib44","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/nau.24695","article-title":"Urinary side effects of psychotropic drugs: a systematic review and metanalysis","volume":"40","author":"Trinchieri","year":"2021","journal-title":"Neurourol. Urodyn."},{"issue":"7","key":"10.1016\/j.jpsychires.2021.10.026_bib45","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/00002512-200825070-00001","article-title":"Drug-induced urinary incontinence","volume":"25","author":"Tsakiris","year":"2008","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.jpsychires.2021.10.026_bib46","first-page":"212","article-title":"Emergencies caused by side effects of psychiatric medications","volume":"12","author":"Tueth","year":"1994","journal-title":"AJEM (Am. J. Emerg. Med.)"},{"issue":"5","key":"10.1016\/j.jpsychires.2021.10.026_bib47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/00002018-200831050-00002","article-title":"Drug-induced urinary retention: incidence, management and prevention","volume":"31","author":"Verhamme","year":"2008","journal-title":"Drug Saf."},{"issue":"1\u20132","key":"10.1016\/j.jpsychires.2021.10.026_bib48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology (Berlin)"},{"issue":"8","key":"10.1016\/j.jpsychires.2021.10.026_bib49","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1177\/0269881113492027","article-title":"A review of the adverse effects and safety of noradrenergic antidepressants","volume":"27","author":"Whiskey","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2021.10.026_bib50","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.jpsychires.2021.10.026_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J. Am. Stat. Assoc."},{"issue":"Suppl. 8","key":"10.1016\/j.jpsychires.2021.10.026_bib52","first-page":"S3","article-title":"Neurophysiology of lower urinary tract function and dysfunction","volume":"5","author":"Yoshimura","year":"2003","journal-title":"Rev. Urol."},{"issue":"3","key":"10.1016\/j.jpsychires.2021.10.026_bib53","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0922-4106(94)90047-7","article-title":"Clozapine is a potent and selective muscarinic M4 receptor agonist","volume":"269","author":"Zorn","year":"1994","journal-title":"Eur. J. Pharmacol."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621006233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395621006233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:27:04Z","timestamp":1758367624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395621006233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":53,"alternative-id":["S0022395621006233"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.10.026","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urological adverse drug reactions of psychotropic medication in psychiatric inpatients \u2013 A drug surveillance report from German-speaking countries","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2021.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}